
The Year in Biotech and What’s Ahead in 2023
The Bio Report
00:00
Alzheimer's Drugs in 2023?
The biggest thing will be Lecadam app and just the rollout in 2023. Biogen was among the companies to name a new CEO, Chris Vibacher,. The one time stenophie CEO is scheduled to speak at JP Morgan conference soon.
Transcript
Play full episode